Pharming Group NV (PHGUF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,674 | N/A | 33,069 | 4,233 | N/A |
| Depreciation Amortization | 2,306 | N/A | 6,216 | 2,190 | N/A |
| Accounts receivable | -5,313 | N/A | 1,155 | -1,462 | N/A |
| Accounts payable and accrued liabilities | -1,211 | N/A | 272 | -1,645 | N/A |
| Other Working Capital | -12,208 | N/A | -4,600 | -5,424 | N/A |
| Other Operating Activity | 10,315 | 0 | -18,889 | 2,717 | 0 |
| Operating Cash Flow | $-22,785 | $N/A | $17,223 | $609 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -215 | N/A | -1,071 | -208 | N/A |
| Purchase Of Investment | N/A | N/A | 7,384 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -591 | -167 | N/A |
| Other Investing Activity | 0 | 0 | -591 | -167 | 0 |
| Investing Cash Flow | $-215 | $N/A | $5,722 | $-375 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 1,124 | 18 | N/A |
| Other Financing Activity | -2,630 | 0 | -6,384 | -2,907 | 0 |
| Financing Cash Flow | $-2,630 | $N/A | $-5,260 | $-2,889 | $N/A |
| Exchange Rate Effect | 3,068 | N/A | -20,906 | 405 | N/A |
| Beginning Cash Position | 207,342 | N/A | 191,924 | 191,924 | N/A |
| End Cash Position | 184,780 | N/A | 188,703 | 189,674 | N/A |
| Net Cash Flow | $-22,562 | $N/A | $-3,221 | $-2,250 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,785 | N/A | 17,223 | 609 | N/A |
| Capital Expenditure | -215 | N/A | -1,071 | -208 | N/A |
| Free Cash Flow | -23,000 | 0 | 16,152 | 401 | 0 |